Table 2.

Effects of CPhGs on the serum AST, ALT activities of hepatic fibrosis rats

Group	Dose (mg/kg/day)	n	ALT (U/L)	AST (U/L)
Normal	—	12	38.12 ± 2.789**	77.82 ± 16.675**
Model	—	11	46.26 ± 6.904	173.27 ± 27.389
BJRG	600	10	39.68 ± 6.716	104.65 ± 8.891**
CPhGs	500	12	39.69 ± 7.048	105.23 ± 8.865**
	250	9	39.98 ± 5.476	106.60 ± 20.270**
	125	10	40.95 ± 3.920	119.72 ± 25.368**

Values are expressed as mean ± SD, n = Survival number of animals

^** P < 0.01, Compared with the model group